Trial
NCT04865419
Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
AstraZeneca
Collaborators
—
Condition
Haematological Malignancies
Intervention
AZD0466
Why stopped
Trial terminated based on benefit-risk profile assessment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-15